Company or institution

FORMA Therapeutics, Inc.

Save Like

172 applicationsfiled 2013 to 2025

Allowance rate

75%

level with the USPTO range 68% to 81%

Rejections before allowance

1.0

−0.6 vs the USPTO

Months to first action

7.7 mo

−10.9 vs the USPTO

Needed an RCE

26%

−1 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds119 apps

A61K Medical preparations36 apps

A61P Therapeutic activity of compounds12 apps

C07C 5 apps

Art units

162462 apps

162553 apps

162610 apps

16129 apps

16237 apps

16276 apps

Examiners met

The examiners seen most, and how it went with each

D Margaret M Seaman27 apps

67%

Brenda Libby Coleman26 apps

96%

Jeffrey H Murray14 apps

50%

Brian J Davis12 apps

92%

Paul V Ward8 apps

100%

Venkataraman Balasubramanian7 apps

86%

John Matthew Mauro5 apps

80%

Kristin Ann Vajda5 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

VALO HEALTH, INC.51 apps

100%

Barnes & Thornburg LLP (FORMA)33 apps

61%

FORMA Therapeutics20 apps

40%

Rigel Pharmaceuticals, Inc.18 apps

94%

POLSINELLI PC (Main Customer Number)11 apps

78%

Jones Day10 apps

43%

NOVO NORDISK INC.9 apps

100%

WOLF GREENFIELD & SACKS, P.C.7 apps

67%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19237221	INHIBITING G CYCLIC AMP-RESPONSIVE ELEMENT-BINDING PROTEIN (CREB) BINDING PROTEIN (…	2025-06-13	Pending	0	0	n/a
19078066	INHIBITING MUTANT IDH-1	2025-03-12	Pending	0	0	n/a
19041868	TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE-1 (IDH-1) MUTATION	2025-01-30	Pending	0	0	n/a
15132698	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15486277	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15804306	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15127526	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15448688	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15445045	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15487269	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 172 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in